Okamoto, I., Araki, J., Suto, R., Shimada, M., Nakagawa, K. and Fukuoka, M. (2006) EGFR Mutation in
Gefitinib-Responsive Small-Cell Lung Cancer. Annals of Oncology, 17, 1028-1029. http://dx.
doi.org/10.1093/annonc/mdj114

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.